News

AmphoTLC™ is a liposomal amphotericin B injection indicated for severe systemic fungal infections such as mucormycosis. The drug is approved in Taiwan and has been marketed and sold for several ...
After being interrogated, the owner of the store revealed that one Shivam Bhati, owner of a Saket-based medical shop, was the source of these vials of Liposomal Amphotericin-B injections.
More recently, noninferiority and a better safety profile for micafungin relative to liposomal amphotericin B were demonstrated for first-line treatment of invasive candidiasis in a study that ...
Sun Pharma has received the Food and Drug Administration’s blessing for generic Amphotericin B Liposome for injection, 50 mg/vial single-dose vial. The product is the generic of AmBisome ...
India's Central Drugs Standard Control Organization has approved Taiwan Liposome Company's (NASDAQ: TLC) marketing application for Amphotericin B Liposome for 50mg Injection for immediate import ...
The Central government has given licence to five companies to ramp up the production of Liposomal Amphotericin B injections, which is used to treat black fungus or mucormycosis, sources told news ...
The government said in May 2021, 3,63,000 vials of Amphotericin-B will be imported, thereby resulting in total availability in the country inclusive of the domestic production of 5,26,752 vials.
Jaipur: Liposomal amphotericin B injection, an investigational drug for the treatment of black fungus or mucormycosis, has been added to the Rajasthan’s list of essential drugs by the state ...
NEW DELHI: The Central government has given licence to five companies to ramp up the production of Liposomal Amphotericin B injections, which is used to treat black fungus or mucormycosis, the ...
The company on May 19 received permission from the Central Drugs Standard Control Organisation to manufacture and market Liposomal Amphotericin B Injection 50mg/vial (Lyophilised), it said in a ...